Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease

Clinical and Experimental Rheumatology

Volumn 33, Issue , 2015, Pages 142-147

  Rizzi, Maurizio ^a   Sarzi Puttini, Piercarlo ^a   Airoldi, Andrea ^a   Antivalle, Marco ^a   Battellino, Michele ^a   Atzeni, Fabiola ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

Author keywords

Carbon monoxide diffusion capacity of the lung; Interstitial lung disease; Six minute walk test; Systemic sclerosis

Indexed keywords

CARBON MONOXIDE; SCL 70 ANTIBODY; BIOLOGICAL MARKER; OXYGEN;

6-MINUTE WALK TEST; ADULT; AGED; ALVEOLAR CAPILLARY MEMBRANE; ARTICLE; BLOOD OXYGEN TENSION; BORG SCALE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC TEST; DISEASE SEVERITY; DYSPNEA; FEMALE; FOLLOW UP; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HIGH RISK PATIENT; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG BLOOD VOLUME; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; OXYGEN DESATURATION; PERFORMANCE; PERFORMANCE CAPACITY; PERIPHERAL CAPILLARY OXYGEN SATURATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RATING SCALE; RESPIRATORY TRACT PARAMETERS; SYSTEMIC SCLEROSIS; TRANSTHORACIC ECHOCARDIOGRAPHY; BLOOD; COMPLICATION; COMPUTER ASSISTED TOMOGRAPHY; EXERCISE TEST; EXERCISE TOLERANCE; HYPERTENSION, PULMONARY; LUNG; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; RADIOGRAPHY; RISK FACTOR; SCLERODERMA, DIFFUSE; TIME; WALKING;

AGED; BIOLOGICAL MARKERS; CARBON MONOXIDE; DYSPNEA; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; OXYGEN; PREDICTIVE VALUE OF TESTS; PULMONARY DIFFUSING CAPACITY; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SCLERODERMA, DIFFUSE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; WALKING;

EID: 84946207331     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. nd ed. Philadelphia, PA: Lippincott, Williams and Wilkins, 2004; pp 63-88.
2. MUKERJEE D, ST GEORGE D, COLEIRO B, KNIGHT C et al.: Prevalence and outcome in systemic sclerosis associated pulmonary hypertension: application of a registry approach. Ann Rheum Dis 2003; 62: 1088-93.
3. TOLLE JJ, WAXMAN AB, VANHORN TL, PAPPAGIANOPOULOS PP, SYSTROM DM: Exercise-induced pulmonary arterial hypertension. Circulation 2008; 118: 2183-9.
4. VILLALBA WO, SAMPAIO-BARROS PD, PEREIRA MC et al:. Six-minute walk test for evaluation of pulmonary disease severity in sclerodermia patients. Chest 2007; 131: 217-22.
5. JENKINS S, CECINS N: Six minute walk test: observed adverse events and oxygen desaturation in a large cohort of patients with chronic lung disease. Intern Med J 2011; 41: 416-22.
6. WALLAERT B, WEMEAU-STERVINOU L, SALLERON J, TILLIE-LEBLOND I, PEREZ T: Do we need exercise test to detect gas exchange impairment in fibrotic idiopathic interstitial pneumonias? Pulm Med 2012; 12: 657180.
7. WEMEAU-STERVINOU L, PEREZ T, MURPHY C, POLGE A-S,WALLAERT B: Lung capillary blood volume and membrane diffusion in idiopathic interstitial pneumonia. Resp Med 2012; 106: 564-70.
8. ALKOTOB ML, SOLTANI P, SHEATT MA et al.: Reduced exercise capacity and stress-induced pulmonary hypertension in patients with sclerodermia. Chest 2006; 130: 176-81.
9. TRAD S, HUONG DLT, FRANCES C et al.: Impaired carbon monoxide diffusing capacity as a marker of limited systemic sclerosis. Eur J Intern Med 2011; 22: e80-e6.
10. SOMEYA F, MUGII N, HASEGAWA M, YAHATA T, NAKAGAWA T: Predictors of exercise-induced oxygen desaturation in systemic sclerosis patients with interstitial lung disease. Respiratory Care 2014; 59: 75-80.
11. GUARNIERI G, ZANATTA E, MASON P et al.: Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis. Clin Exp Rheumatol 2015; 33 (Suppl. 91): S80-86.
12. REED J, POPE JE: A comparison between general rheumatologists and scleroderma experts with respect to following systemic sclerosis guidelines. Clin Exp Rheumatol 2015; 33 (Suppl. 91): S40-46.
13. BARSOTTI S, BELLANDO RANDONE S, GUIDUCCI S, DELLA ROSSA A: Systemic sclerosis: a critical digest of the recent literature. Clin Exp Rheumatol 2014; 32 (Suppl. 86): S194-205.
14. BORG G: Psychophysical basis of perceived exertion. Med Sci Sparts Exerc 1982; 14: 377-81.
15. MILLER MR, HANKINSON J, BRUSASCO V et al.: ATS/ERS Task force standardisation of spirometry. Eur Respir J 2005; 26: 319-38.
16. WANGER J, CLAUSEN JL, COATES A et al.: Standardisation of the measurements of lung volumes. Eur Respir J 2005; 26: 511-22.
17. MacINTYRE N, CRAPO RO, VIEGI G et al.: Standardisation of the single breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26: 720-35.
18. PELLEGRINO R, VIEGI G, BRUSASCO V et al.: Interpretative strategies for lung function test. Eur Respir J 2005; 26 (Vol.): 948-68.
19. MOHSNIFAR Z, TASKIN DP: Effects of carboxyhemoglobin on single breath diffusing capacity: derivation of an empirical correction factor. Respiration 1979; 37: 158-91.
20. ROUGHTON FJW, FOSTER RE: Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in the human lung, with special reference to true diffusing capacity of pulmonary membrane and volume of blood in the capillaries. J Appl Physiol 1957; 11: 277-89.
21. Aamerican Thoracic SocietTy: ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-17.
22. CAMARRI R, EASTWOOD PR, CECINS NM, THOMPSON PJ, JENKINS S: Six-minute walk distance in healthy subjects aged 55-75 years. Resir Med 2006; 100: 658-63.
23. MacLEOD DB, CORTINEZ LI, KEIFER JC: The desaturation response time of finger pulse oximeters during mild hypothermia. Anaesthesia 2005; 60: 65-71.
24. MALERBA M, RADAELI A, RAGNOLI B et al.: Exahaled nitric oxide levels in systemic sclerosis with and without pulmonary involvement. Chest 2007; 132 (Vol.): 575-80.
25. American Thoracic Society/European Respiratory Society International Multidisclinary Consensus Classification of the Idiopatic Interstitial Pneumonias. Am J Respir Crit Care Med 2002; 165: 277-304.
26. MEUNE C, AVOUAC J, WAHBI K et al.: Cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography during routine care: a controlled study of 100 consecutive patients. Arthritis Rheum 2008; 58: 1803-9.
27. SCHACHNA L, WIGLEY FM, CHANG B, WITH B, WISE RA, GELBER AC: Age and risk of pulmonary arterial hypertension in sclerodermia. Chest 2003; 124: 2098-104.
28. PIMENTA SP, BARBOSA da ROCHA R, BALDIB. G, Dde MELO KAWASSAKI A, ADIB KAIRALLA R, RIBEIRO CARVALHO CR: Desaturation - distance ratio: a new concept for a functional assessment of interstitial lung disease. Clnics Science 2010; 65: 841-6.
29. LAMA VN, FLAHERTY KR, TOEWS GB et al.: Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Resp Crit Care Med 2003; 168: 1084-90.
30. HALLSTRAND TS, BOITANO LJ, JOHSON WC, SPADA CA, HAYES JG, RAGHU G: The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis. Eur Respir J 2005; 25: 96-103.
31. BICHILE I, BICHILE T, EHSAN A, KHARAJE J: Six minute walk test as an assessment tool in systemic sclerosis. Internet Journal of Rheumatology 2008; 6.
32. BOUROS D, WELLS AU, NICHOLSON AG, COLBY TV et al.: Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002; 165: 1581-6.
33. WALKER UA, TYNDALL A, CZIRJAK I et al.: EUSTAR Co-authors: Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis 2007; 66: 754-63.
34. SPENGLER ML, SVETAZ MJ, LEROUX MB, LEIVA ML, BOTTAI HM: Association between capillaroscopy, haemorheological variables and plasma proteins in patients bearing Raynaud's phenomenon. Clin Hemorheol Microcirc 2004; 30: 17-24.
35. HUEZ S, ROUFUSSE F, VACHIERY JL et al.: Isolated right ventricular dysfunction in systemic sclerosis: latent pulmonary hypertension? Eur Respir J 2007; 30: 928-38.
36. DIOT E, BOISSINOT E, ASQUIER E et al.: Relationship between abnormalities on high-resolution CT and pulmonary function in systemic sclerosis. Chest 1998; 114: 1623-9.
37. OVERBEEK MJ, GROEPENHOFF H, VOSKUYL AE et al.: Membrane diffusion and capillary blood volume measurements are not useful as sceening tools for pulmonary arterial hypertension in systemic sclerosis: a case control study. Respir Res 2008; 9: 68-75.